Anti-cyclic citrullinated peptide antibody predicts the development of rheumatoid arthritis in patients with undifferentiated arthritis

BACKGROUND: Clinical outcomes of undifferentiated arthritis (UA) are diverse, and only 40% of patients with UA develop rheumatoid arthritis (RA) after 3 years. Discovering predictive markers at disease onset for further intervention is critical. Therefore, our objective was to analyze the clinical o...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chun, Zhang, Yan, Song, Hui, Gao, Jie, Zhao, Dong-Bao, Zhu, Qi, He, Dong-Yi, Wang, Li, Li, Xiang-Pei, Liu, Xu-Dong, Xiao, Wei-Guo, Wu, Xin-Yu, Wu, Hua-Xiang, Tu, Wei, Hu, Shao-Xian, Wang, Xin, Li, Zhi-Jun, Lu, Zhi-Min, Da, Zhan-Yun, Liang, Bo, Liu, Xiao-Min, Zhao, Jin-Wei, Li, Ling, Han, Feng, Qi, Wu-Fang, Wei, Wei, Ma, Xu, Li, Zhen-Bin, Zheng, Gui-Min, Zhang, Feng-Xiao, Li, Yi, Wang, You-Lian, Ling, Guang-Hui, Chen, Jin-Wei, Hou, Xiao-Qiang, Zhang, Jing, Chen, Qing-Ping, Liu, Chang-Lian, Zeng, Jia-Shun, Zou, Qing-Hua, Fang, Yong-Fei, Su, Yin, Li, Zhan-Guo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964957/
https://www.ncbi.nlm.nih.gov/pubmed/31855969
http://dx.doi.org/10.1097/CM9.0000000000000570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964957/
https://www.ncbi.nlm.nih.gov/pubmed/31855969
http://dx.doi.org/10.1097/CM9.0000000000000570

Ejemplares similares